Stocks and Investing Stocks and Investing
Tue, January 31, 2023
[ 12:00 AM ] - WOPRAI
David Barden Maintained (TMUS) at Strong Buy and Held Target at $175 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
PJ Juvekar Maintained (TSE) at Hold with Increased Target to $29 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
George Galliers Maintained (ALV) at Strong Buy with Increased Target to $115 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Alexander Paris Reiterated (AMG) at Buy and Held Target at $155 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (TFX) at Hold with Decreased Target to $260 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Terry McEvoy Downgraded (TFC) to Hold and Held Target at $53 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Brady Gailey Maintained (TFIN) at Hold with Decreased Target to $62 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Mike Cikos Maintained (TENB) at Strong Buy with Increased Target to $48 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Andrew Terrell Maintained (TCBK) at Buy with Decreased Target to $56 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Stephen Trent Maintained (ALK) at Strong Buy with Increased Target to $59 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
John Roberts Maintained (ALB) at Sell with Increased Target to $240 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Robert Ottenstein Maintained (STZ) at Buy with Increased Target to $260 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Edward Reilly Maintained (SWAG) at Strong Buy with Decreased Target to $4.5 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
James Ricchiuti Maintained (SYM) at Strong Buy with Increased Target to $18 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Mark Delaney Maintained (SYM) at Hold with Increased Target to $14 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Richard Newitter Maintained (SYK) at Hold with Increased Target to $257 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
David Feaster Maintained (STEL) at Buy with Decreased Target to $31 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Andreas Argyrides Initiated (SPRY) at Buy and Held Target at $10 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Catherine Mealor Maintained (SSB) at Buy with Decreased Target to $100 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Timothy Chiodo Maintained (SOFI) at Hold with Decreased Target to $7.5 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Dominick Gabriele Maintained (SOFI) at Buy with Increased Target to $7 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Adelson Maintained (SOFI) at Hold with Increased Target to $6 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Gaurav Jain Maintained (SMG) at Buy with Increased Target to $90 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (SMG) at Hold with Increased Target to $60 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Bradley Canino Initiated (SNDX) at Strong Buy and Held Target at $37 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Chris Shibutani Maintained (BNTX) at Hold with Decreased Target to $156 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Ben Gerlinger Downgraded (BSRR) to Hold and Held Target at $24 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
James Hardiman Maintained (CCL) at Hold with Increased Target to $13 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Jonathan Atkin Maintained (CCI) at Buy with Increased Target to $162 on, Jan 31st, 2023
[ 12:00 AM ] - WOPRAI
Andrew Cooper Maintained (CDNA) at Strong Buy with Decreased Target to $24 on, Jan 31st, 2023

Andrew Cooper Maintained (CDNA) at Strong Buy with Decreased Target to $24 on, Jan 31st, 2023


Published on 2024-10-28 01:13:42 - WOPRAI, Andrew Cooper
  Print publication without navigation


Andrew Cooper of Raymond James, Maintained "CareDx, Inc" (CDNA) at Strong Buy with Decreased Target from $26 to $24 on, Jan 31st, 2023.

Andrew has made no other calls on CDNA in the last 4 months.



There are 2 other peers that have a rating on CDNA. Out of the 2 peers that are also analyzing CDNA, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew

  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $28 on, Monday, November 7th, 2022
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Friday, November 4th, 2022
Contributing Sources